Home RXi Pharmaceuticals Announces Completion of Enrollment in Second Phase 1 Trial for RXI-109 Program
 

Keywords :   


RXi Pharmaceuticals Announces Completion of Enrollment in Second Phase 1 Trial for RXI-109 Program

2013-01-31 09:52:58| Biotech - Topix.net

RXi Pharmaceuticals Corporation , a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that its second Phase 1 study with their anti-scarring drug, RXI-109, for the management of surgical and hypertrophic scars and ... (more)

Tags: program trial phase completion

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11
23.11 NEXT
23.11
23.11(Rawlings)
23.11 DVD2
23.11
23.11 US Orig LP The Soul Searchers Salt Of ~
23.11Switch SR SL LED 2
More »